Notice Information
Notice Title
NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care
Notice Description
NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.
Lot Information
Lot 1 - aQIV
NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Lot 2 - QIV-HDNHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Lot 3 - QIVcNHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
Options: option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Renewal: The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Lot 4 - QIVrNHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Lot 5 - QIVeNHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points
Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-02aa9d
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/022304-2021
- Current Stage
- Award
- All Stages
- Tender, Award
Procurement Classification
- Notice Type
- Tender Notice
- Procurement Type
- Framework
- Procurement Category
- Goods
- Procurement Method
- Open
- Procurement Method Details
- Open procedure
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33651660 - Influenza vaccines
Notice Value(s)
- Tender Value
- £29,200,000 £10M-£100M
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- Not specified
Notice Dates
- Publication Date
- 8 Sep 20214 years ago
- Submission Deadline
- 2 Jun 2021Expired
- Future Notice Date
- Not specified
- Award Date
- 17 Aug 20214 years ago
- Contract Period
- 31 Aug 2021 - 31 Aug 2022 6-12 months
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Cancelled
- Awards Status
- Active, Unsuccessful
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Contact Name
- Philip Grieve
- Contact Email
- philip.grieve@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- RUNCORN
- Postcode
- WA7 2ES
- Post Town
- Warrington
- Country
- England
-
- Major Region (ITL 1)
- TLD North West (England)
- Basic Region (ITL 2)
- TLD7 Merseyside
- Small Region (ITL 3)
- TLD71 East Merseyside
- Delivery Location
- Not specified
-
- Local Authority
- Halton
- Electoral Ward
- Halton Lea
- Westminster Constituency
- Runcorn and Helsby
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-02aa9d-2021-09-08T15:50:13+01:00",
"date": "2021-09-08T15:50:13+01:00",
"ocid": "ocds-h6vhtk-02aa9d",
"description": "RESPONDING TO THIS NOTICE:Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific informationThis procurement exercise will be conductedon the eTendering portal athttps://healthfamily.force.com/s/WelcomeCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specificinformation (if requested) through the eTendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal athttps://health-family.force.com/s/Welcome andclick the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue titleto select- review opportunity details and click \"Register Interest\"- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (ifyou decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance whencompleting responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide their company profile in the Government's Supplier Registration Service (which has replacedsid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will still be on the system), candidates must go to thefollowing web pagehttps://supplierregistration.cabinetoffice.gov.uk and select \"Register\" at the top of the page. Key in details as requested to search for yourcompany. If you do not have a D-U-N-S(r)Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the message function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or togetheras members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services orgoods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcareor health related services.",
"initiationType": "tender",
"tender": {
"id": "CM/PHS/20/5623",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
},
"mainProcurementCategory": "goods",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.",
"value": {
"amount": 29200000,
"currency": "GBP"
},
"lots": [
{
"id": "1",
"title": "Lot 1 - aQIV",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "10%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "3%"
},
{
"type": "price",
"description": "87%"
}
]
}
},
{
"id": "2",
"title": "Lot 2 - QIV-HD",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "10%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "3%"
},
{
"type": "price",
"description": "87%"
}
]
}
},
{
"id": "3",
"title": "Lot 3 - QIVc",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": true,
"renewal": {
"description": "The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "10%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "3%"
},
{
"type": "price",
"description": "87%"
}
]
}
},
{
"id": "4",
"title": "Lot 4 - QIVr",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "10%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "3%"
},
{
"type": "price",
"description": "87%"
}
]
}
},
{
"id": "5",
"title": "Lot 5 - QIVe",
"description": "NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points",
"contractPeriod": {
"startDate": "2021-09-01T00:00:00+01:00",
"endDate": "2022-08-31T23:59:59+01:00"
},
"hasRenewal": false,
"submissionTerms": {
"variantPolicy": "notAllowed"
},
"hasOptions": true,
"options": {
"description": "option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months."
},
"status": "cancelled",
"awardCriteria": {
"criteria": [
{
"name": "Security of Supply",
"type": "quality",
"description": "10%"
},
{
"name": "Ease of Use",
"type": "quality",
"description": "3%"
},
{
"type": "price",
"description": "87%"
}
]
}
}
],
"items": [
{
"id": "1",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
},
"relatedLot": "1"
},
{
"id": "2",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
},
"relatedLot": "2"
},
{
"id": "3",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
},
"relatedLot": "3"
},
{
"id": "4",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
},
"relatedLot": "4"
},
{
"id": "5",
"additionalClassifications": [
{
"scheme": "CPV",
"id": "33651660",
"description": "Influenza vaccines"
}
],
"deliveryAddresses": [
{
"region": "UK"
},
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Please refer to Document 4d as issued with the ITO Documents for the list of purchasing points (Schedule 8 of Document 3 refers)"
},
"relatedLot": "5"
}
],
"submissionMethod": [
"electronicSubmission",
"written"
],
"submissionMethodDetails": "http://health.atamis.co.uk",
"communication": {
"atypicalToolUrl": "http://health.atamis.co.uk"
},
"documents": [
{
"id": "economic",
"documentType": "economicSelectionCriteria"
},
{
"id": "technical",
"documentType": "technicalSelectionCriteria"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"techniques": {
"hasFrameworkAgreement": true
},
"coveredBy": [
"GPA"
],
"tenderPeriod": {
"endDate": "2021-06-02T13:00:00+01:00"
},
"submissionTerms": {
"languages": [
"en"
],
"bidValidityPeriod": {
"endDate": "2021-08-31T23:59:59+01:00"
}
},
"awardPeriod": {
"startDate": "2021-06-02T13:00:00+01:00"
},
"bidOpening": {
"date": "2021-06-02T13:00:00+01:00",
"address": {
"streetAddress": "Runcorn"
},
"description": "Commercial Medicines Unit Employee"
},
"hasRecurrence": false,
"contractTerms": {
"hasElectronicOrdering": true,
"electronicInvoicingPolicy": "allowed",
"hasElectronicPayment": true
}
},
"parties": [
{
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)",
"identifier": {
"legalName": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"address": {
"streetAddress": "2nd Floor, Rutland House",
"locality": "Runcorn",
"region": "UK",
"postalCode": "WA7 2ES",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "Philip Grieve",
"email": "philip.grieve@nhs.net",
"url": "http://health.atamis.co.uk"
},
"roles": [
"buyer",
"centralPurchasingBody"
],
"details": {
"url": "https://www.england.nhs.uk/",
"buyerProfile": "https://www.england.nhs.uk/",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "MINISTRY",
"description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
}
},
{
"id": "GB-FTS-497",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "generaloffice@administrativecourtoffice.justice.gov.uk"
},
"roles": [
"reviewBody"
],
"details": {
"url": "https://www.gov.uk/courts-tribunals"
}
},
{
"id": "GB-FTS-27864",
"name": "Seqirus UK Limited",
"identifier": {
"legalName": "Seqirus UK Limited"
},
"address": {
"streetAddress": "Point, 29 Market Street",
"locality": "Maidenhead",
"region": "UK",
"postalCode": "SL6 8AA",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-27865",
"name": "Aventis Pharma ltd t/a Sanofi",
"identifier": {
"legalName": "Aventis Pharma ltd t/a Sanofi"
},
"address": {
"streetAddress": "410 Thames Valley, Park Drive, Reading",
"locality": "Reading",
"region": "UK",
"postalCode": "RG6 1PT",
"countryName": "United Kingdom"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
}
],
"buyer": {
"id": "GB-FTS-2505",
"name": "The NHS Commissioning Board (operating under the name of NHS England)"
},
"language": "en",
"awards": [
{
"id": "022304-2021-CM/PHS/20/5623-1",
"relatedLots": [
"1"
],
"title": "aQIV",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-27864",
"name": "Seqirus UK Limited"
}
]
},
{
"id": "022304-2021-CM/PHS/20/5623-2",
"relatedLots": [
"3"
],
"title": "QIVc",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-27864",
"name": "Seqirus UK Limited"
}
]
},
{
"id": "022304-2021-CM/PHS/20/5623-3",
"relatedLots": [
"4"
],
"title": "QIVr",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-27865",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "022304-2021-CM/PHS/20/5623-4",
"relatedLots": [
"5"
],
"title": "QIVe",
"status": "active",
"suppliers": [
{
"id": "GB-FTS-27865",
"name": "Aventis Pharma ltd t/a Sanofi"
}
]
},
{
"id": "022304-2021-5",
"status": "unsuccessful",
"statusDetails": "unsuccessful"
}
],
"contracts": [
{
"id": "022304-2021-CM/PHS/20/5623-1",
"awardID": "022304-2021-CM/PHS/20/5623-1",
"title": "aQIV",
"status": "active",
"dateSigned": "2021-08-18T00:00:00+01:00"
},
{
"id": "022304-2021-CM/PHS/20/5623-2",
"awardID": "022304-2021-CM/PHS/20/5623-2",
"title": "QIVc",
"status": "active",
"dateSigned": "2021-08-18T00:00:00+01:00"
},
{
"id": "022304-2021-CM/PHS/20/5623-3",
"awardID": "022304-2021-CM/PHS/20/5623-3",
"title": "QIVr",
"status": "active",
"dateSigned": "2021-08-18T00:00:00+01:00"
},
{
"id": "022304-2021-CM/PHS/20/5623-4",
"awardID": "022304-2021-CM/PHS/20/5623-4",
"title": "QIVe",
"status": "active",
"dateSigned": "2021-08-18T00:00:00+01:00"
}
],
"bids": {
"statistics": [
{
"id": "3",
"measure": "bids",
"relatedLot": "1",
"value": 2
},
{
"id": "10",
"measure": "bids",
"relatedLot": "3",
"value": 2
},
{
"id": "17",
"measure": "bids",
"relatedLot": "4",
"value": 2
},
{
"id": "24",
"measure": "bids",
"relatedLot": "5",
"value": 2
},
{
"id": "4",
"measure": "smeBids",
"relatedLot": "1",
"value": 0
},
{
"id": "11",
"measure": "smeBids",
"relatedLot": "3",
"value": 0
},
{
"id": "18",
"measure": "smeBids",
"relatedLot": "4",
"value": 0
},
{
"id": "25",
"measure": "smeBids",
"relatedLot": "5",
"value": 0
},
{
"id": "5",
"measure": "foreignBidsFromEU",
"relatedLot": "1",
"value": 2
},
{
"id": "12",
"measure": "foreignBidsFromEU",
"relatedLot": "3",
"value": 2
},
{
"id": "19",
"measure": "foreignBidsFromEU",
"relatedLot": "4",
"value": 2
},
{
"id": "26",
"measure": "foreignBidsFromEU",
"relatedLot": "5",
"value": 2
},
{
"id": "6",
"measure": "foreignBidsFromNonEU",
"relatedLot": "1",
"value": 0
},
{
"id": "13",
"measure": "foreignBidsFromNonEU",
"relatedLot": "3",
"value": 0
},
{
"id": "20",
"measure": "foreignBidsFromNonEU",
"relatedLot": "4",
"value": 0
},
{
"id": "27",
"measure": "foreignBidsFromNonEU",
"relatedLot": "5",
"value": 0
},
{
"id": "7",
"measure": "electronicBids",
"relatedLot": "1",
"value": 2
},
{
"id": "14",
"measure": "electronicBids",
"relatedLot": "3",
"value": 2
},
{
"id": "21",
"measure": "electronicBids",
"relatedLot": "4",
"value": 2
},
{
"id": "28",
"measure": "electronicBids",
"relatedLot": "5",
"value": 2
},
{
"id": "1",
"measure": "lowestValidBidValue",
"relatedLot": "1",
"value": 1,
"currency": "GBP"
},
{
"id": "8",
"measure": "lowestValidBidValue",
"relatedLot": "3",
"value": 1,
"currency": "GBP"
},
{
"id": "15",
"measure": "lowestValidBidValue",
"relatedLot": "4",
"value": 1,
"currency": "GBP"
},
{
"id": "22",
"measure": "lowestValidBidValue",
"relatedLot": "5",
"value": 1,
"currency": "GBP"
},
{
"id": "2",
"measure": "highestValidBidValue",
"relatedLot": "1",
"value": 1,
"currency": "GBP"
},
{
"id": "9",
"measure": "highestValidBidValue",
"relatedLot": "3",
"value": 1,
"currency": "GBP"
},
{
"id": "16",
"measure": "highestValidBidValue",
"relatedLot": "4",
"value": 1,
"currency": "GBP"
},
{
"id": "23",
"measure": "highestValidBidValue",
"relatedLot": "5",
"value": 1,
"currency": "GBP"
}
]
}
}